|
Press Releases |
|
 |
|
Tuesday, March 31, 2020 |
|
Kingworld Medicines Seizes the Opportunity Foster the Diversified Development of Product Specifications |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater healthcare products and services industry in China, has announced its unaudited annual results for the year ended 31 December 2019 (the "Year Under Review"). more info >> |
|
Thursday, January 23, 2020 |
|
疫情牵动人心,预防为主 |
近日,全国人民的注意力都被一种快速传播的疾病——新型冠状病毒感染的肺炎牵制,受该病毒感染的患者一般会出现发热、乏力、干咳、逐渐出现呼吸困难,严重者出现急性呼吸窘迫综合症、脓毒症休克、难以纠正的代谢性酸中毒、出现凝血功能障碍、甚至死亡。 more info >> |
|
疫情牽動人心,預防為主 |
近日,全國人民的注意力都被一種快速傳播的疾病─新型冠狀病毒感染的肺炎牽制,受該病毒感染的患者一般會出現發熱、乏力、乾咳、逐漸出現呼吸困難,嚴重者出現急性呼吸窘迫綜合症、膿毒症休克、難以糾正的代謝性酸中毒、出現凝血功能障礙、甚至死亡。 more info >> |
|
Tuesday, August 27, 2019 |
|
金活25周年稳步前进 逐健康追梦征程 |
中国领先及全球知名大健康产品服务的全渠道供应链企业 - 金活医药集团有限公司(「金活医药」或「集团」,股份代号:01110.HK)公布截至2019年6月30日止六个月(「回顾期」)未经审核之中期业绩。 more info >> |
|
金活25週年穩步前進 逐健康追夢征程 |
中國領先及全球知名大健康產品服務的全渠道供應鏈企業 - 金活醫藥集團有限公司(「金活醫藥」或「集團」,股份代號:01110.HK)公佈截至2019年6月30日止六個月(「回顧期」)未經審核之中期業績。
more info >> |
|
Steady Development in Kingworld 25th Anniversary and Deepening Management New Journey in Pursuit of Quality and Healthy Living |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading global well-known omni-channel enterprise offering a complete supply chain spanning the greater health products and services industry, has announced its unaudited interim results for the six months ended 30 June 2019 (the "Period"). more info >> |
|
Thursday, March 28, 2019 |
|
金活医药强化销售策略与渠道覆盖 引进新产品优化结构 念慈菴枇杷膏销售大幅增长25.6% |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司(「金活医药」或「集团」,股份代号:01110.HK)公布截至2018年12月31日止年度(「回顾年度」)经审核之全年业绩。 more info >> |
|
金活醫藥強化銷售策略與渠道覆蓋 引進新產品優化結構 念慈菴枇杷膏銷售大幅增長25.6% |
中國領先及全球知名大健康產品服務的全鏈條全渠道供應鏈企業 - 金活醫藥集團有限公司(「金活醫藥」或「集團」,股份代號:01110.HK)公佈截至2018年12月31日止年度(「回顧年度」)經審核之全年業績。 more info >> |
|
Kingworld Medicines Strengthening Sales Strategy and Channel Coverage; Optimizing Structure by Introducing New Products; Sales of Nin Jiom Significantly Increased by 25.6% |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater health products and services industry in China, has announced its audited annual results for the year ended 31 December 2018 (the "Year Under Review"). more info >> |
|
Wednesday, August 29, 2018 |
|
金活医药2018年上半年收益稳步提升,同比增长9.3%;本公司拥有人应占溢利上升24.4%至人民币2,755万元 |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司(「金活医药」或「集团」,股份代号:01110.HK)欣然公布截至2018年6月30日止六个月(「回顾期」)未经审核之中期业绩。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
Aug 18, 2025 14:38 JST
|
|
|
Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
Aug 18, 2025 10:35 HKT/SGT
|
|
|
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
Aug 18, 2025 10:30 HKT/SGT
|
|
|
勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
Aug 18, 2025 10:23 HKT/SGT
|
|
|
Anime Tokyo Station Surpasses 200,000 Visitors
Aug 18, 2025 11:00 JST
|
|
|
斩获12金14银11铜 摘得大满贯!首程控股多家被投企业闪耀世界人形机器人运动会
Aug 18, 2025 09:57 HKT/SGT
|
|
|
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Aug 18, 2025 9:11 JST
|
|
|
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 16, 2025 15:27 HKT/SGT
|
|
|
WL Delicious Announced 2025 Interim Results
Aug 16, 2025 15:25 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 16, 2025 14:54 HKT/SGT
|
|
|
How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT/SGT
|
|
|
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|